AAAAAA
Results:
1-21
|
Results: 21
Authors:
Bargman, JM
Thorpe, KE
Churchill, DN
Citation: Jm. Bargman et al., Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study, J AM S NEPH, 12(10), 2001, pp. 2158-2162
Authors:
Lipscombe, J
Bargman, JM
Citation: J. Lipscombe et Jm. Bargman, Fibrate-induced increase in blood urea and creatinine, NEPH DIAL T, 16(7), 2001, pp. 1515-1515
Authors:
Menon, MK
Naimark, DM
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: Mk. Menon et al., Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function, NEPH DIAL T, 16(11), 2001, pp. 2207-2213
Authors:
de la Cruz, MC
Dimkovic, N
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: Mc. De La Cruz et al., Is catheter function influenced by the side of the body in which the peritoneal dialysis catheter is placed?, PERIT DIA I, 21(5), 2001, pp. 526-526
Authors:
Prakashan, KP
Annigeri, RA
Chu, M
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: Kp. Prakashan et al., Local application of mupirocin at the peritoneal catheter exit site prevents early postoperative infections and should become standard practice, PERIT DIA I, 21(5), 2001, pp. 526-527
Authors:
Sasal, J
Naimark, D
Klassen, J
Shea, J
Bargman, JM
Citation: J. Sasal et al., Late renal transplant failure: An adverse prognostic factor at initiation of peritoneal dialysis, PERIT DIA I, 21(4), 2001, pp. 405-410
Authors:
Lipscombe, J
Lewis, GF
Cattran, D
Bargman, JM
Citation: J. Lipscombe et al., Deterioration in renal function associated with fibrate therapy, CLIN NEPHR, 55(1), 2001, pp. 39-44
Authors:
Singhal, MK
Bhaskaran, S
Vidgen, E
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: Mk. Singhal et al., Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it, PERIT DIA I, 20(4), 2000, pp. 429-438
Authors:
Bhaskaran, S
Schaubel, DE
Jassal, SV
Thodis, E
Singhal, MK
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: S. Bhaskaran et al., The effect of small solute clearances on survival of anuric peritoneal dialysis patients, PERIT DIA I, 20(2), 2000, pp. 181-187
Authors:
Zhong, AM
Billa, V
Rotstein, LE
Wong, PY
Bargman, JM
Vas, SI
Oreopoulos, DG
Citation: Am. Zhong et al., Recurrence of hyperparathyroidism after total parathyroidectomy and autotransplantation in peritoneal dialysis patients, PERIT DIA I, 20(2), 2000, pp. 200-208
Authors:
Blake, PG
Korbet, SM
Blake, R
Bargman, JM
Burkart, JM
Delano, BG
Dasgupta, MK
Fine, A
Finkelstein, F
McCusker, FX
McMurray, SD
Zabetakis, PM
Zimmerman, SW
Heidenheim, P
Citation: Pg. Blake et al., A multicenter study of noncompliance with continuous ambulatory peritonealdialysis exchanges in US and Canadian patients, AM J KIDNEY, 35(3), 2000, pp. 506-514
Authors:
Lajoie, G
Leung, R
Bargman, JM
Citation: G. Lajoie et al., Clinical, biochemical, and pathological features in a patient with plasma cell dyscrasia and Fanconi syndrome, ULTRA PATH, 24(4), 2000, pp. 221-226
Authors:
Bargman, JM
Citation: Jm. Bargman, Non-infectious complications of peritoneal dialysis, TEXTBOOK OF PERITONEAL DIALYSIS, 2ND EDITION, 2000, pp. 609-646
Authors:
Prichard, SS
Bargman, JM
Citation: Ss. Prichard et Jm. Bargman, The use of peritoneal dialysis in special situations, TEXTBOOK OF PERITONEAL DIALYSIS, 2ND EDITION, 2000, pp. 737-754
Authors:
Blake, PG
Bargman, JM
Bick, J
Cartier, P
Dasgupta, MK
Fine, A
Lavoie, SD
Spanner, E
Taylor, PA
Citation: Pg. Blake et al., Chapter 5: Guidelines for adequacy and nutrition in peritoneal dialysis, J AM S NEPH, 10, 1999, pp. S311-S321
Authors:
Vas, SI
Conly, J
Bargman, JM
Oreopoulos, DG
Citation: Si. Vas et al., Resistance to mupirocin: No indication of it to date while using mupirocinointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients, PERIT DIA I, 19(4), 1999, pp. 313-314
Authors:
Vas, SI
Bargman, JM
Citation: Si. Vas et Jm. Bargman, Vaccination for peritoneal dialysis patients, PERIT DIA I, 19(2), 1999, pp. 115-116
Authors:
Fried, L
Hutchison, A
Stegmayr, B
Prichard, S
Bargman, JM
Citation: L. Fried et al., Recommendations for the treatment of lipid disorders in patients on peritoneal dialysis, PERIT DIA I, 19(1), 1999, pp. 7-16
Authors:
James, LR
Lajoie, G
Prajapati, D
Gan, BS
Bargman, JM
Citation: Lr. James et al., Calciphylaxis precipitated by ultraviolet light in a patient with end-stage renal disease secondary to systemic lupus erythematosus, AM J KIDNEY, 34(5), 1999, pp. 932-936
Authors:
Bargman, JM
Citation: Jm. Bargman, Management of minimal lesion glomerulonephritis: Evidence-based recommendations, KIDNEY INT, 55, 1999, pp. S3-S16
Authors:
Thodis, E
Vas, SI
Bargman, JM
Singhal, M
Chu, M
Oreopoulos, DG
Citation: E. Thodis et al., Nystatin prophylaxis: Its inability to prevent fungal peritonitis patientson continuous ambulatory peritoneal dialysis, PERIT DIA I, 18(6), 1998, pp. 583-589
Risultati:
1-21
|